Literature DB >> 21906869

Treatment of steroid refractory, Gamma Knife related radiation necrosis with bevacizumab: case report and review of the literature.

Matthew R Sanborn1, Shabbar F Danish, Myrna R Rosenfeld, Donald O'Rourke, John Y K Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21906869     DOI： 10.1016/j.clineuro.2011.08.007

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN： 0303-8467            Impact factor:   1.876


× No keyword cloud information.
  13 in total

1.  An analysis of radiation necrosis of the central nervous system treated with bevacizumab.

Authors:  Karen Tye; Herbert H Engelhard; Konstantin V Slavin; M Kelly Nicholas; Steven J Chmura; Young Kwok; Dominic S Ho; Ralph R Weichselbaum; Matthew Koshy
Journal:  J Neurooncol       Date:  2014-02-07       Impact factor: 4.130

Review 2.  Antiangiogenic therapy for glioblastoma.

Authors:  Elizabeth R Gerstner; Tracy T Batchelor
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

3.  The Effectiveness of Bevacizumab in Radionecrosis After Radiosurgery of a Single Brain Metastasis.

Authors:  Durim Delishaj; Stefano Ursino; Francesco Pasqualetti; Ilaria Pesaresi; Ilaria Desideri; Mirco Cosottini; Concetta Laliscia; Fabiola Paiar; Maria Grazia Fabrini
Journal:  Rare Tumors       Date:  2015-12-29

4.  Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.

Authors:  Abigail L Stockham; Manmeet Ahluwalia; Chandana A Reddy; John H Suh; Aryavarta Kumar; Michael A Vogelbaum; Gene H Barnett; Erin S Murphy; Samuel T Chao
Journal:  J Neurooncol       Date:  2013-09-18       Impact factor: 4.130

5.  Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study.

Authors:  J P Boström; M Seifert; S Greschus; N Schäfer; M Glas; G Lammering; U Herrlinger
Journal:  Strahlenther Onkol       Date:  2014-01-17       Impact factor: 3.621

6.  A new strategy of CyberKnife treatment system based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema.

Authors:  Yang Wang; Enmin Wang; Li Pan; Jiazhong Dai; Nan Zhang; Xin Wang; Xiaoxia Liu; Guanghai Mei; Xiaofang Sheng
Journal:  J Neurooncol       Date:  2014-05-31       Impact factor: 4.130

7.  Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery.

Authors:  Christopher P Deibert; Manmeet S Ahluwalia; Jason P Sheehan; Michael J Link; Toshinori Hasegawa; Shoji Yomo; Wu Han Feng; Pan Li; John C Flickinger; L Dade Lunsford; Douglas Kondziolka
Journal:  J Neurooncol       Date:  2013-08-09       Impact factor: 4.130

8.  Changes in protein level in the cerebrospinal fluid of a patient with cerebral radiation necrosis treated with bevacizumab.

Authors:  Hirohito Yano; Noriyuki Nakayama; Kasumi Morimitsu; Manabu Futamura; Naoyuki Ohe; Kazuhiro Miwa; Jun Shinoda; Toru Iwama
Journal:  Clin Med Insights Oncol       Date:  2014-12-09

Review 9.  Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature.

Authors:  Durim Delishaj; Stefano Ursino; Francesco Pasqualetti; Agostino Cristaudo; Mirco Cosottini; Maria Grazia Fabrini; Fabiola Paiar
Journal:  J Clin Med Res       Date:  2017-02-21

10.  Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.

Authors:  Yang Wang; Li Pan; Xiaofang Sheng; Yin Mao; Yu Yao; Enmin Wang; Nan Zhang; Jiazhong Dai
Journal:  Eur J Med Res       Date:  2012-08-23       Impact factor: 2.175
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.